Our findings also highlight the importance of ongoing surveillance of MPO‐antibody titres and clinical features of vasculitis on follow‐up, as MPO‐antibody positivity and features of MPA‐ILD may manifest many years later. The gene discussed is MPO; the disease is vasculitis.